EPAZ Stock | News | Quote | Stock Forum |

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
$EPAZ Epazz, Inc. EPAZ Company Overview 

Epazz, Inc. EPAZ Current Price and Quotes
Last Price 0.0005
Previous Close 0.0005 Open 0.0005
Daily Range 0.0006 - 0.0004 52wk Range 0.0039 - 0.0003
Volume 98,269,815 Dividend N/A
Average Vol (3m) 8,838,165 Yield N/A

EPAZ Stock Message Board http://investorshangout.com/search?q=EPAZ&...mp;yt1=Go!

Last Updated:

Epazz, Inc. EPAZ

Company Updated Profile
Company Information

205 W. Wacker Dr.
Suite 1320
Chicago, IL 60606

Website: http://www.epazz.com
Phone: (312) 955-8161
Find us on:    

Epazz, Inc. EPAZ
Epazz Inc. is an enterprise-wide cloud software company that specializes in providing customized web applications to the corporate world, higher education institutions and the public sector. Epazz unique BoxesOS applications can create virtual communities for enhanced communication, provide information and content for decision-making, and create a secure marketplace for any type of commerce all through the medium of the Internet. Epazz is the answer to the increasing information technology dema...



Epazz, Inc. EPAZ
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Sep 30, 2013 10-Q
CIK 0001335239
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 7372 - Prepackaged software
Business Status SPAC a/o Jun 18, 2008
Incorporated In: IL, USA
Year of Inc. 1999
Employees 8 a/o Mar 22, 2013
Company Officers/Contacts

Shaun Passley CEO, CFO, President
Company Directors

Shaun Passley Chairman
Service Providers

Auditor/Accountant
M&K CPAS, PLLC
4100 North Sam Houston Pkwy W
Houston, TX, 77086
United States

Legal Counsel
The Loev Law Firm, PC
6300 West Loop South
Bellaire, TX, 77401
United States

Investor Relations Firm
Not Available

Epazz, Inc. EPAZ
EPAZ Security Details

Share Structure

Market Value1 $1,734,179 a/o Feb 13, 2014
Shares Outstanding 3,468,358,708 a/o Nov 18, 2013
Float 251,394,176 a/o Jul 10, 2013
Authorized Shares 6,000,000,000 a/o Jul 10, 2013
Par Value  0.01
Shareholders

Shareholders of Record 54 a/o Jul 10, 2013
Security Notes

Capital Change=shs decreased by 1 for 10 split. Pay date=08/24/2010.
Short Selling Data

Short Interest 0 (-100%)
Jan 31, 2014
Significant Failures to Deliver  No
Transfer Agent(s)

Island Stock Transfer

Epazz, Inc. EPAZ Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 1,193 736 705
Cost of Revenue - - -
Gross Profit 1,193 736 705
Operating Expenses

Research and Development - - -
Sales, General and Admin. 2,364 637 405
Non-Recurring Items 3 82 -
Other 275 177 106
Operating Income (1,449) (161) 194
Income From Continuing Operations

Add'l Income/Expense Items (137) - -
Earnings Before Interest and Tax (1,586) (161) 194
Interest Expense 320 176 73
Earnings Before Tax (1,907) (337) 121
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (1,907) (337) 121
Non Recurring Events

Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (1,907) (337) 121
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (1,907) (337) 121

Epazz, Inc. EPAZ Recent News

Feb 13, 2014 Epazz K9Bytes Renewed Over 90% of Our Support Plans
Feb 6, 2014 Epazz Agreed to Acquire Small Business Software Company; Epazz Expects to Add 5% Increase to Recurring Revenue Stream
Jan 31, 2014 Epazz Expects to Add 15% Increase to Recurring Revenue Stream; Signs Letter of Intent to Acquire Help Desk Software Company
Jan 8, 2014 Epazz K9 Bytes: New 24/7/365 Support Plans Cause Renewal Revenue to Increase Over 40%
Dec 19, 2013 Epazz's K9 Bytes Subsidiary Launches K9Kloud.com E-Commerce Website and the Future Home for K9Bytes Cloud Services
Dec 12, 2013 Epazz's K9 Bytes Subsidiary Doubles Sales in November Due to Growing Demand for Its Products and Services
Dec 10, 2013 Epazz Forms Terran Power, Inc. for Project Human Mobile Power Spinoff to Enter the $20 Billion Smartphone-Accessories Market


EPAZ Epazz, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=EPAZ&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/EPAZ/quote
Stock Chart http://www.otcmarkets.com/stock/EPAZ/chart
Company Info http://www.otcmarkets.com/stock/EPAZ/company-info
Recent News http://www.otcmarkets.com/stock/EPAZ/news
Financials http://www.otcmarkets.com/stock/EPAZ/financials
Filings and Disclosure http://www.otcmarkets.com/stock/EPAZ/filings
Short Sales http://www.otcmarkets.com/stock/EPAZ/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/EPAZ/insider-transactions
Research Reports http://www.otcmarkets.com/stock/EPAZ/research
Summary http://finance.yahoo.com/q?s=EPAZ
Historical Prices http://finance.yahoo.com/q/hp?s=EPAZ+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=EPAZ
Basic Chart http://finance.yahoo.com/q/bc?s=EPAZ+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=EPAZ+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=EPAZ+Headlines
Press Releases http://finance.yahoo.com/q/p?s=EPAZ+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=EPAZ+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=EPAZ+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=EPAZ+Industry
Major Holders http://finance.yahoo.com/q/mh?s=EPAZ+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=EPAZ+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=EPAZ+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=EPAZ
Balance Sheet http://finance.yahoo.com/q/bs?s=EPAZ
Cash Flow http://finance.yahoo.com/q/cf?s=EPAZ+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/EPAZ
Market Watch http://www.marketwatch.com/investing/stock/EPAZ
Bloomberg http://www.bloomberg.com/quote/EPAZ:US
Morningstar http://quotes.morningstar.com/stock/s?t=EPAZ
Bussinessweek http://investing.businessweek.com/research/st...icker=EPAZ
Barchart http://www.barchart.com/quotes/stocks/EPAZ
OTC Short Report http://otcshortreport.com/index.php?index=EPAZ
Investopedia http://www.investopedia.com/markets/stocks/EPAZ/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 15

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 31

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 55

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

Eco Wave Power Expands Wave Energy Project in Europe

Updated Category News Views 229

Eco Wave Power Initiates Key Infrastructure Enhancements Eco Wave Power Global AB (publ) (NASDAQ: WAVE) is excited to unveil plans for crucial upgrades at its groundbreaking wave energy project. This groundbreaking initiative is set to harness ocean wave energy to produce clean electricity efficiently. Eco Wave Power, recognized as a leading company in onshore wave energy...

Continue Reading
Key Managerial Transactions Reported by Danske Bank A/S

Updated Category News Views 162

Recent Mandatory Transaction Notifications by Danske Bank A/S Danske Bank A/S is committed to transparency in financial transactions involving its managerial personnel. This communication signifies the bank's adherence to the EU Market Abuse Regulation and the requirements set by the Danish Financial Supervisory Authority (FSA) and Nasdaq Copenhagen. Understanding...

Continue Reading
Strategic Insights into Symbotic's Options Market Activity

Updated Category News Views 187

Overview of Options Activity for Symbotic Recently, significant investors have demonstrated a notably bearish outlook on Symbotic. This trend has been evidenced by the options activity surrounding the company's stock, symbolized by SYM. The strong presence of whales entering the market indicates a shift in investor sentiment, with nuances that are crucial for...

Continue Reading
South Coast AQMD Takes Action on Oil Facilities During Violations

Updated Category News Views 267

South Coast AQMD Addresses Oil Site Violations In a determined effort to safeguard public health and air quality, the South Coast Air Quality Management District (South Coast AQMD) has recently taken enforcement action against three oil and gas facilities in Los Angeles. These actions were prompted by public complaints and confirmed violations of air quality regulations,...

Continue Reading
BAM UK & Ireland and LoadSpring Solutions Innovate Project Management

Updated Category News Views 199

BAM UK & Ireland and LoadSpring Solutions Innovate Project Management BAM UK & Ireland, a prominent name in the construction and engineering sector, has taken a bold step forward by partnering with LoadSpring Solutions. This collaboration aims to revolutionize project management through an innovative solution known as LoadSpring INSIGHTS™. This groundbreaking platform...

Continue Reading